ABSTRACT The molecular mechanism of growth hormone release by synthetic somatocrinin was investigated on purified hog anterior pituitary secretory granules; the granules were found to contain a cAMP-dependent protein kinase that catalyzed [y-32P]-ATP histone phosphorylation with maximal rates ranging from 1 to 5 nmol of Pi incorporated per mg of protein per 20 min. The activity of this enzyme was further stimulated by somatocrinin. Stimulation was observed at concentrations as low as 0.3 pM, and the half-maximal effect was obtained with 35 ± 8 pM (n = 4). Michaelis-Menten analysis of phosphorylation kinetics suggested that the peptide did not change significantly the reaction's Vma,,, but produced a dramatic increase in enzyme affinity for cAMP: the apparent Km for the nucleotide decreased from 400 x 10-9 M under unstimulated conditions to 15 x 10-9 M in the presence of 100 pM somatocrinin. Furthermore, a Hill plot of concentration-dependence curve indicated the existence of negative cooperativity. At the concentration of 35 pM, the less potent analogs of somatocrinin [designated hpGRF-44 to indicate source (human pancreas, hp), activity (growth hormone-releasing factor, GRF), and amino acid composition], hpGRF-(1-37) and [Phe1]hpGRF-(1-40) had 20% and 7%, respectively, of the effect of somatocrinin. The biologically inactive analog hpGRF-(2-40) had no evident effect at concentrations up to 0.1 ,uM. Therefore, we suggest that somatocrinin stimulation of growth hormone release involves activation of exocytosis through a phosphorylation mechanism mediated by a granular receptor coupled with a cAMP-dependent protein kinase.
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The recent identification of somatocrinin, a 44-amino acid peptide with high intrinsic activity to stimulate secretion of growth hormone (GH) (1) (2) (3) (4) (5) , has opened new perspectives in the study of hypothalamic control of somatotrophic cells; somatocrinin has been designated hpGRH-44 to indicate the source (human pancreas, hp), the activity (growth hormone-releasing factor, GRH), and the amino acid content. Previous characterization of somatostatin had indeed provided new and important insights into several physiological and biochemical aspects of GHsecretion inhibition (6) (7) (8) . As yet, however, no comprehensive model has emerged that could account for the mechanism of somatostatin inhibition on a molecular basis. Moreover, because the inhibitory effect of somatostatin is not restricted to the somatotrophs but also occurs in a variety of target cells, this mechanism is likely to involve a ubiquitous receptor not specific to GH secretion (9) . By contrast, there is strong evidence that somatocrinin is highly specific for stimulating GH secretion (2) .
Preliminary approaches to the mechanism of somatocrinin action already have been attempted. These involved both the native somatocrinin purified either from rat hypothalami (10) or from a human pancreatic tumor (1, 5) and a chemical replicate prepared by total solid-phase synthesis (11) . Results demonstrated that native and synthetic somatocrinins had an identical stimulatory effect on GH release in vitro, with the halfmaximal concentration at about 15 pM. They also showed that the effect occurred rapidly (within seconds) and did not require de novo hormone biosynthesis. In addition, they suggested implication of cAMP as intracellular mediator (4) .
On the basis of these findings, we have investigated the biochemical evidence that could support a cAMP-mediated activating effect of somatocrinin on GH-granule exocytosis.
MATERUIL AND METHODS Synthetic somatocrinin was prepared by solid-phase technique and tested for biological activity as detailed (1) .
Hog pituitary glands were collected fresh at the slaughter house and rapidly frozen. Anterior pituitaries were dissected from the frozen glands, and secretory granules were purified by the method of Labrie et al. (12) with minor modifications. Briefly, the tissue was homogenized in 1 mM NaHCO3 solution containing 0.01% bacitracin as protease inhibitor. Homogenate was centrifuged for 15 min at 2,000 X g (rotor 70 Ti, Beckman centrifuge L5-65). The supernatant was discarded and the pellet was resuspended and centrifuged for 15 min at 1,220 X g. The supernatant resulting from this centrifugation was collected and centrifuged at 30,000 x g for 30 min. The pellet obtained showed a brown top layer that was carefully discarded and a white bottom layer that was resuspended and submitted to 30,000 X g for a 30-min centrifugation. The pellet of this centrifugation was resuspended in 47.5% sucrose solution (density, 1.18 g/cm3), layered on top of a 58.3% sucrose solution (density, 1.22 g/cm3), and centrifuged for 2 hr at 95,000 X g. The resulting pellet contained the secretory granules.
For electron microscopic study, the granules were fixed in 0.1% glutaraldehyde for 30 min at 00C and postfixed for 1 hr in 2% osmium tetroxide at room temperature. After dehydration in ethanol and embedding in Epon, ultrathin sections were cut, stained with uranyl acetate and observed with a Siemens Elmiskop 1A microscope. Granular protein kinase activity was assayed by estimating 32p incorporation in type II calf thymus histones (Sigma) as described (13). Incubation medium contained 11 mM MgCl2, 10 mM NaF, 40 ,uM ATP, 1.5 mg of histones per ml, 0-5 ,uM cAMP, 0.6 mM isobutylmethylxanthine, 0.02% bacitracin, and 0.2 ,uCi (1 Ci = 37 GBq) of [ y-32P]ATP. The reaction was started by the addition of granules (300 ,ug/ml). It was run for 20 min at 30°C
Abbreviations: hpGRF-44, 44-amino acid growth hormone-releasing factor from human pancreas; hpGRF-(1-37), hpGRF-(1-40), and hpGRF-(2-40) are the fragments corresponding to sequences 1-37, 1-40, and 2-40 inclusive of hpGRF-44; GH, growth hormone. 6538 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. and stopped by applying the samples onto 2 cm x 2 cm 3MM Whatman paper filters. The filters were first washed for 20 min in 20% trichloroacetic acid then five times for 5 min in 10% trichloroacetic acid. Afterwards the radioactivity was measured.
All reagents were of the purest grade available from Sigma. Rabbit-muscle heat-stable Walsh's inhibitor of cAMP-dependent protein kinases (Sigma) was dialyzed before use. Protein concentrations were determined as described by Lowry (14) .
RESULTS
Electron microscopic observation suggested that the granule fraction had a relatively high degree of purity: nuclei and mitochondria were apparently absent, and membrane fragments were only occasionally seen as expected from the high density of the centrifugation medium (Fig. 1) .
The granules catalyzed histone phosphorylation by ATP at basal rates ranging, according to preparations, from 1 to 5 nmol of Pi incorporated per mg of protein per 20 min. Furthermore, the phosphorylation was stimulated by cAMP. The cAMP stimulation was concentration dependent, with a maximal 2-fold increase at 5 AM cAMP (6.0 ± 1.9 nmol of Pi incorporated per mg of protein per 20 min) and an apparent half-maximal effect at 0.30 ± 0.07 AuM cAMP (mean value ± SEM from four separate experiments). In the further presence of 100 pM somatocrinin, the effect of a given concentration of cAMP was significantly enhanced for lower concentrations but was not modified for maximal concentration. This resulted in a dramatic decrease in the apparent half maximal cAMP concentration, with no change in the maximal phosphorylation level. The ef- fect was fully blocked by 90,000 units of purified Walsh's inhibitor (15) per ml (which also blocked unstimulated activity) (Fig. 2) . In the range studied (i.e., from 0 to 5 u.LM cAMP), the kinetics of histone phosphorylation for both basal and somatocrinin-stimulated activities were Michaelian functions of cAMP concentration, and Lineweaver-Burk representation (Fig. 3) was consistent with the hypothesis that somatocrinin acts by decreasing the Km for cAMP without affecting the Vma,, of the reaction. Thus, in the absence of somatocrinin, the apparent Km for cAMP was 400 X 10-9 M as compared to 15 X 10-9 M in the presence of 100 pM somatocrinin. The concentration dependence of somatocrinin stimulation was investigated in the presence of 0.05 ,uM cAMP (this concentration corresponded to the maximal effect of somatocrinin in Fig. 2) . Basal phos- [PhelIhpGRF-(1-40) (9) , and hpGRF-( (Fig. 4) . Analysis of the data according to Hill (16) indicated the presence of negative cooperativity (Fig. 5) . (4, 9) .
From a general viewpoint, the proposal that somatocrinin stimulates GH release by a phosphorylating mechanism is consistent with the concept that somatostatin inhibition would be itself mediated by a dephosphorylation process (9) . Additional studies are required to elucidate the identity of the putative protein whose phosphorylation-dephosphorylation balance would regulate granule exocytosis.
